BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Shen H, Zhangyuan G, Huang R, Zhang W, He Q, Jin K, Zhuo H, Zhang Z, Wang J, Sun B, Lu X. 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes. Cell Death Dis 2018;9:159. [PMID: 29415983 DOI: 10.1038/s41419-017-0180-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Anderson G. Tumor Microenvironment and Metabolism: Role of the Mitochondrial Melatonergic Pathway in Determining Intercellular Interactions in a New Dynamic Homeostasis. Int J Mol Sci 2022;24. [PMID: 36613754 DOI: 10.3390/ijms24010311] [Reference Citation Analysis]
2 Fan K, Zhu K, Wang J, Ni X, Shen S, Gong Z, Cheng X, Zhang C, Liu H, Suo T, Ni X, Liu H. Inhibition of 14-3-3ε by K50 acetylation activates YAP1 to promote cholangiocarcinoma growth. Exp Cell Res 2022;421:113404. [PMID: 36341908 DOI: 10.1016/j.yexcr.2022.113404] [Reference Citation Analysis]
3 Niu ZS, Wang WH, Niu XJ. Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World J Gastroenterol 2022; 28(46): 6433-6477 [DOI: 10.3748/wjg.v28.i46.6433] [Reference Citation Analysis]
4 Han H, Jin W, Li X. Mesenchymal stem cells-based therapy in liver diseases. Mol Biomed 2022;3:23. [DOI: 10.1186/s43556-022-00088-x] [Reference Citation Analysis]
5 Wang G, Luo G, Zhao M, Miao H. Significance of exosomes in hepatocellular carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1056379] [Reference Citation Analysis]
6 Reale A, Khong T, Spencer A. Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment. J Clin Med 2022;11. [PMID: 36498469 DOI: 10.3390/jcm11236892] [Reference Citation Analysis]
7 Wu Q, Fu S, Xiao H, Du J, Cheng F, Wan S, Zhu H, Li D, Peng F, Ding X, Wang L. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics. Adv Sci (Weinh) 2023;10:e2204814. [PMID: 36373730 DOI: 10.1002/advs.202204814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yeung CLS, Yam JWP. Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma. Semin Cancer Biol 2022;86:1088-101. [PMID: 35158067 DOI: 10.1016/j.semcancer.2022.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Aseervatham J. Interactions between 14-3-3 Proteins and Actin Cytoskeleton and Its Regulation by microRNAs and Long Non-Coding RNAs in Cancer. Endocrines 2022;3:665-702. [DOI: 10.3390/endocrines3040057] [Reference Citation Analysis]
10 Lee Y, Kim JH. The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology. Clin Mol Hepatol 2022;28:706-24. [PMID: 35232008 DOI: 10.3350/cmh.2021.0390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ding J, Zhao W. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma. Cancer Manag Res 2022;14:2735-48. [PMID: 36133739 DOI: 10.2147/CMAR.S373165] [Reference Citation Analysis]
12 Wang X, Huang J, Chen W, Li G, Li Z, Lei J. The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Exp Mol Med 2022. [PMID: 36138197 DOI: 10.1038/s12276-022-00855-4] [Reference Citation Analysis]
13 Jangholi A, Müller Bark J, Kenny L, Vasani S, Rao S, Dolcetti R, Punyadeera C. Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma. Biochim Biophys Acta Rev Cancer 2022;1877:188784. [PMID: 36028150 DOI: 10.1016/j.bbcan.2022.188784] [Reference Citation Analysis]
14 Tian BW, Han CL, Dong ZR, Tan SY, Wang DX, Li T. Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:4036. [PMID: 36011030 DOI: 10.3390/cancers14164036] [Reference Citation Analysis]
15 Sun Q, Lin S, Zhang M, Gong Y, Ma H, Tran NT, Zhang Y, Li S. SpRab11a-Regulated Exosomes Inhibit Bacterial Infection through the Activation of Antilipopolysaccharide Factors in Crustaceans. The Journal of Immunology 2022;209:710-722. [DOI: 10.4049/jimmunol.2200094] [Reference Citation Analysis]
16 Guan M, Wang M, Wang W, Li C, Yao L, Zhu H, Yang T. Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma. Liver Research 2022. [DOI: 10.1016/j.livres.2022.08.001] [Reference Citation Analysis]
17 Tsuchiya A, Natsui K, Ishii Y, Koseki Y, Takeda N, Tomiyoshi K, Yamazaki F, Yoshida Y, Terai S. Small extracellular vesicles and liver diseases: From diagnosis to therapy. World J Hepatol 2022; 14(7): 1307-1318 [DOI: 10.4254/wjh.v14.i7.1307] [Reference Citation Analysis]
18 Tang Q, Yang S, He G, Zheng H, Zhang S, Liu J, Wei S, Fan Q, Peng X, Li X, Zhang D, Yang L, Li H. Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy. Cancer Lett 2022;:215823. [PMID: 35835409 DOI: 10.1016/j.canlet.2022.215823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bauzá-Martinez J, Armony G, Pronker MF, Wu W. Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL). J Extracell Vesicles 2022;11:e12245. [PMID: 35918900 DOI: 10.1002/jev2.12245] [Reference Citation Analysis]
20 Jia W, Zhang T, Yao Q, Li J, Nie Y, Lei X, Mao Z, Wang Y, Shi W, Song W. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. Front Immunol 2022;13:870458. [DOI: 10.3389/fimmu.2022.870458] [Reference Citation Analysis]
21 Lee C, Han J, Jung Y. Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease. Biology 2022;11:637. [DOI: 10.3390/biology11050637] [Reference Citation Analysis]
22 Hussain MWA, Jahangir S, Ghosh B, Yesmin F, Anis A, Satil SN, Anwar F, Rashid MH. Exosomes for Regulation of Immune Responses and Immunotherapy. JNT 2022;3:55-85. [DOI: 10.3390/jnt3010005] [Reference Citation Analysis]
23 Li S, Chen L. Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma. Front Oncol 2022;12:793432. [PMID: 35155236 DOI: 10.3389/fonc.2022.793432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Chen X, Chi H, Zhao X, Pan R, Wei Y, Han Y, Granito A. Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2521025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Hao Q, Wu Y, Wu Y, Wang P, Vadgama JV. Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. Int J Mol Sci 2022;23:1461. [PMID: 35163380 DOI: 10.3390/ijms23031461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
26 Bao Q, Huang Q, Chen Y, Wang Q, Sang R, Wang L, Xie Y, Chen W. Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment. Front Mol Biosci 2021;8:796385. [PMID: 35059436 DOI: 10.3389/fmolb.2021.796385] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
27 Wang G, Kenific CM, Lieberman G, Zhang H, Lyden D. Systemic Regulation of Metastatic Disease by Extracellular Vesicles and Particles. The Systemic Effects of Advanced Cancer 2022. [DOI: 10.1007/978-3-031-09518-4_2] [Reference Citation Analysis]
28 Patil K, Dermime S, Uddin S. Decoding the functional role of extracellular vesicles in hepatocellular carcinoma: implications in clinical theranostics. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 2022. [DOI: 10.1016/b978-0-323-99283-1.00016-1] [Reference Citation Analysis]
29 Hao Y, Chen P, Zhang X, Shao Y, Xu Y, Qian W. The effects of tumor‐derived exosomes on T‐cell function and efficacy of cancer immunotherapy. ImmunoMedicine 2021;1. [DOI: 10.1002/imed.1029] [Reference Citation Analysis]
30 Ma F, Vayalil J, Lee G, Wang Y, Peng G. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. J Immunother Cancer 2021;9:e003217. [PMID: 34642246 DOI: 10.1136/jitc-2021-003217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
31 Chakravarti R. Immune regulations by 14-3-3: A misty terrain. Immunobiology 2021;226:152145. [PMID: 34628289 DOI: 10.1016/j.imbio.2021.152145] [Reference Citation Analysis]
32 Miao L, Zhang Z, Ren Z, Li Y. Application of Immunotherapy in Hepatocellular Carcinoma. Front Oncol 2021;11:699060. [PMID: 34513678 DOI: 10.3389/fonc.2021.699060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Li B, Cao Y, Sun M, Feng H. Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy. FASEB J 2021;35:e21916. [PMID: 34510546 DOI: 10.1096/fj.202100294RR] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
34 Zhao L, Ma X, Yu J. Exosomes and organ-specific metastasis. Mol Ther Methods Clin Dev 2021;22:133-47. [PMID: 34485600 DOI: 10.1016/j.omtm.2021.05.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kim H, Zhao Q, Barreda H, Kaur G, Hai B, Choi JM, Jung SY, Liu F, Lee RH. Identification of Molecules Responsible for Therapeutic Effects of Extracellular Vesicles Produced from iPSC-Derived MSCs on Sjo¨gren's Syndrome. Aging Dis 2021;12:1409-22. [PMID: 34527418 DOI: 10.14336/AD.2021.0621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Li Q, Cai S, Li M, Salma KI, Zhou X, Han F, Chen J, Huyan T. Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy. Int J Nanomedicine 2021;16:5395-409. [PMID: 34408415 DOI: 10.2147/IJN.S313912] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
37 Lee YT, Tran BV, Wang JJ, Liang IY, You S, Zhu Y, Agopian VG, Tseng HR, Yang JD. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3076. [PMID: 34203086 DOI: 10.3390/cancers13123076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
38 Wang X, Zhou Y, Ding K. Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review). Int J Oncol 2021;59:44. [PMID: 34013358 DOI: 10.3892/ijo.2021.5224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
39 Xue D, Han J, Liu Y, Tuo H, Peng Y. Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review). Cancer Biol Ther 2021;22:279-90. [PMID: 33847207 DOI: 10.1080/15384047.2021.1898728] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
40 Qi X, Chen S, He H, Wen W, Wang H. The role and potential application of extracellular vesicles in liver cancer. Sci China Life Sci 2021;64:1281-94. [PMID: 33847910 DOI: 10.1007/s11427-020-1905-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Del Vecchio F, Martinez-Rodriguez V, Schukking M, Cocks A, Broseghini E, Fabbri M. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells. J Extracell Vesicles 2021;10:e12075. [PMID: 33815694 DOI: 10.1002/jev2.12075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
42 He R, Wang Z, Shi W, Yu L, Xia H, Huang Z, Liu S, Zhao X, Xu Y, Yam JWP, Cui Y. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value. Biomed Pharmacother 2021;138:111529. [PMID: 34311529 DOI: 10.1016/j.biopha.2021.111529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
43 Kong JS, Park JH, Yoo SA, Kim KM, Bae YJ, Park YJ, Cho CS, Hwang D, Kim WU. Dynamic transcriptome analysis unveils key proresolving factors of chronic inflammatory arthritis. J Clin Invest 2020;130:3974-86. [PMID: 32407294 DOI: 10.1172/JCI126866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
44 Zhao H, Jiang S. MiR-204-5p Performs a Protective Effect on Cerulein-Induced Rat Pancreatic Acinar Cell AR42J Cell Damage by Targeting Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma and Regulating PI3K/Hippo Pathways. Pancreas 2021;50:243-50. [PMID: 33565802 DOI: 10.1097/MPA.0000000000001748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Liang B, Hu X, Ding Y, Liu M. Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets. J Cell Physiol 2021;236:4138-51. [PMID: 33275291 DOI: 10.1002/jcp.30197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
46 Thietart S, Rautou PE. Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view. J Hepatol 2020;73:1507-25. [PMID: 32682050 DOI: 10.1016/j.jhep.2020.07.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
47 Golonka RM, Vijay-Kumar M. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome. Adv Cancer Res 2021;149:171-255. [PMID: 33579424 DOI: 10.1016/bs.acr.2020.10.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
48 Zhu L, Sun HT, Wang S, Huang SL, Zheng Y, Wang CQ, Hu BY, Qin W, Zou TT, Fu Y, Shen XT, Zhu WW, Geng Y, Lu L, Jia HL, Qin LX, Dong QZ. Isolation and characterization of exosomes for cancer research. J Hematol Oncol 2020;13:152. [PMID: 33168028 DOI: 10.1186/s13045-020-00987-y] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 23.0] [Reference Citation Analysis]
49 Kugeratski FG, Kalluri R. Exosomes as mediators of immune regulation and immunotherapy in cancer. FEBS J 2021;288:10-35. [PMID: 32910536 DOI: 10.1111/febs.15558] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 17.0] [Reference Citation Analysis]
50 Mroweh M, Decaens T, Marche PN, Macek Jilkova Z, Clément F. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E5250. [PMID: 32722054 DOI: 10.3390/ijms21155250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
51 Wan Z, Dong Y, Wei M, Gao X, Yang G, Zhang J, Liu L. Exosomes in Tumor Immunotherapy: Mediator, Drug Carrier, and Prognostic Biomarker. Adv Biosys 2020;4:2000061. [DOI: 10.1002/adbi.202000061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
52 Wu Q, Fan H, Lang R, Li X, Zhang X, Lv S, He Q. Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients. Biomed Res Int 2020;2020:8435420. [PMID: 32685532 DOI: 10.1155/2020/8435420] [Reference Citation Analysis]
53 Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Front Immunol 2020;11:940. [PMID: 32499786 DOI: 10.3389/fimmu.2020.00940] [Cited by in Crossref: 164] [Cited by in F6Publishing: 186] [Article Influence: 54.7] [Reference Citation Analysis]
54 Lin Y, Sun L, Ye X. Expression of yhwaz and gene regulation network in hepatocellular carcinoma. Oncol Lett 2020;19:3971-81. [PMID: 32382342 DOI: 10.3892/ol.2020.11481] [Reference Citation Analysis]
55 Zhou X, Xie F, Wang L, Zhang L, Zhang S, Fang M, Zhou F. The function and clinical application of extracellular vesicles in innate immune regulation. Cell Mol Immunol 2020;17:323-34. [PMID: 32203193 DOI: 10.1038/s41423-020-0391-1] [Cited by in Crossref: 105] [Cited by in F6Publishing: 111] [Article Influence: 35.0] [Reference Citation Analysis]
56 Zongyi Y, Xiaowu L. Immunotherapy for hepatocellular carcinoma. Cancer Letters 2020;470:8-17. [DOI: 10.1016/j.canlet.2019.12.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 31.7] [Reference Citation Analysis]
57 Wang H, Lu Z, Zhao X. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer. J Hematol Oncol. 2019;12:133. [PMID: 31815633 DOI: 10.1186/s13045-019-0806-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 103] [Article Influence: 22.3] [Reference Citation Analysis]
58 Lu Y, Duan Y, Xu Q, Zhang L, Chen W, Qu Z, Wu B, Liu W, Shi L, Wu D, Yang Y, Sun D, Chen X. Circulating exosome-derived bona fide long non-coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma. J Cell Mol Med. 2020;24:1311-1318. [PMID: 31811749 DOI: 10.1111/jcmm.14783] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
59 Wang Y, Dattmore DA, Wang W, Pohnert G, Wolfram S, Zhang J, Yang R, Decker EA, Lee KSS, Zhang G. trans, trans-2,4-Decadienal, a lipid peroxidation product, induces inflammatory responses via Hsp90- or 14-3-3ζ-dependent mechanisms. J Nutr Biochem 2020;76:108286. [PMID: 31918337 DOI: 10.1016/j.jnutbio.2019.108286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
60 Wang X, He Q, Shen H, Xia A, Tian W, Yu W, Sun B. TOX promotes the exhaustion of antitumor CD8(+) T cells by preventing PD1 degradation in hepatocellular carcinoma. J Hepatol 2019;71:731-41. [PMID: 31173813 DOI: 10.1016/j.jhep.2019.05.015] [Cited by in Crossref: 135] [Cited by in F6Publishing: 137] [Article Influence: 33.8] [Reference Citation Analysis]
61 Wang T, Nasser MI, Shen J, Qu S, He Q, Zhao M. Functions of Exosomes in the Triangular Relationship between the Tumor, Inflammation, and Immunity in the Tumor Microenvironment. J Immunol Res 2019;2019:4197829. [PMID: 31467934 DOI: 10.1155/2019/4197829] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
62 Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World J Gastroenterol 2019; 25(25): 3151-3167 [PMID: 31333308 DOI: 10.3748/wjg.v25.i25.3151] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
63 Han Q, Zhao H, Jiang Y, Yin C, Zhang J. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape. Cells. 2019;8. [PMID: 31181729 DOI: 10.3390/cells8060558] [Cited by in Crossref: 56] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
64 Wu Q, Zhou L, Lv D, Zhu X, Tang H. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression. J Hematol Oncol 2019;12:53. [PMID: 31142326 DOI: 10.1186/s13045-019-0739-0] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 26.5] [Reference Citation Analysis]
65 Yin C, Han Q, Xu D, Zheng B, Zhao X, Zhang J. SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC. Oncoimmunology 2019;8:1601479. [PMID: 31143524 DOI: 10.1080/2162402X.2019.1601479] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 16.0] [Reference Citation Analysis]
66 D'Errico G, Alonso-Nocelo M, Vallespinos M, Hermann PC, Alcalá S, García CP, Martin-Hijano L, Valle S, Earl J, Cassiano C, Lombardia L, Feliu J, Monti MC, Seufferlein T, García-Bermejo L, Martinelli P, Carrato A, Sainz B Jr. Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance. Oncogene 2019;38:5469-85. [PMID: 30936462 DOI: 10.1038/s41388-019-0803-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
67 Sasaki R, Kanda T, Yokosuka O, Kato N, Matsuoka S, Moriyama M. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside. Int J Mol Sci 2019;20:E1406. [PMID: 30897788 DOI: 10.3390/ijms20061406] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 13.3] [Reference Citation Analysis]
68 Meldolesi J. Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases. Clin Exp Immunol 2019;196:318-27. [PMID: 30756386 DOI: 10.1111/cei.13274] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
69 Wu AY, Ueda K, Lai CP. Proteomic Analysis of Extracellular Vesicles for Cancer Diagnostics. Proteomics 2019;19:e1800162. [PMID: 30334355 DOI: 10.1002/pmic.201800162] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
70 Chen Y, Xue K, Zhang X, Zheng Z, Liu K. Exosomes derived from mature chondrocytes facilitate subcutaneous stable ectopic chondrogenesis of cartilage progenitor cells. Stem Cell Res Ther 2018;9:318. [PMID: 30463592 DOI: 10.1186/s13287-018-1047-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 10.4] [Reference Citation Analysis]
71 Wang T, Zheng X, Li R, Liu X, Wu J, Zhong X, Zhang W, Liu Y, He X, Liu W, Wang H, Zeng H. Integrated bioinformatic analysis reveals YWHAB as a novel diagnostic biomarker for idiopathic pulmonary arterial hypertension. J Cell Physiol 2019;234:6449-62. [PMID: 30317584 DOI: 10.1002/jcp.27381] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
72 Liu F, Liu Y, Chen Z. Tim-3 expression and its role in hepatocellular carcinoma. J Hematol Oncol. 2018;11:126. [PMID: 30309387 DOI: 10.1186/s13045-018-0667-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
73 Liu H, Li B. The functional role of exosome in hepatocellular carcinoma. J Cancer Res Clin Oncol 2018;144:2085-95. [PMID: 30062486 DOI: 10.1007/s00432-018-2712-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
74 Wang X, Shen H, He Q, Tian W, Xia A, Lu XJ. Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cells. J Med Genet 2019;56:29-31. [PMID: 29997128 DOI: 10.1136/jmedgenet-2018-105439] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]